Adiponectin is a potential catabolic mediator in osteoarthritis cartilage
Arthritis Research & Therapy2010Vol. 12(6), pp. R231–R231
Citations Over TimeTop 10% of 2010 papers
Eun Ha Kang, Yun Jong Lee, Tae Kyun Kim, Chong Bum Chang, Jin‐Haeng Chung, Kichul Shin, Eun Young Lee, Eun Bong Lee, Yeong Wook Song
Abstract
Adiponectin causes matrix degradation in OA cartilage and increases MMPs and iNOS expression via the AMPK and JNK pathways in human OA chondrocytes. The catabolic effects of adiponectin may be counteracted by NO.
Related Papers
- → A mathematical model of adiponectin resistance(2020)8 cited
- → Disparity in circulating adiponectin multimers between term and preterm infants(2009)5 cited
- → Measurement of high-molecular-weight adiponectin is not useful in assessing coronary stenosis(2012)1 cited
- → Concentration of cord serum adiponectin in normal and gestational diabetic pregnancies(2011)1 cited
- → Adiponectin(2010)